MATTHEW TAYLOR MD
Prescription History 1457439713
Medical Genetics - Clinical Genetics (M.D.) in Aurora, CO
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MATTHEW TAYLOR MD, an active Clinical Genetics (M.D.) specialist practicing in Aurora, CO. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 76 documented patient claims. Among these therapy options, the most frequently utilized medication is Cerdelga, which accounts for 25 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other CO PrescribersVs. CO Avg |
|---|---|---|---|
| CerdelgaEliglustat Tartrate | 25 | $30,711.05 | ▲ More than typical |
About Cerdelga: This medication is used for long-term treatment of a certain rare genetic problem (Gaucher's disease). Show more ▾ Eliglustat works by decreasing the amount of a certain natural fatty substance (glucosylceramide) that builds up due to this condition. This can improve symptoms of Gaucher's disease, such as bruising, tiredness, pain in the joints/bones, and a swollen liver/spleen. In 2023, this provider wrote 25 Medicare prescriptions for Cerdelga, about 1.6 times the volume of the typical Colorado prescriber of this medication (16). Medicare paid an average of $30,711.05 per fill, versus $30,535.34 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CO prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25.2 30-Day Fills standardized to 30-day supplies 718 Days of Medication total across all patients in 2023 | |||
| StrensiqAsfotase Alfa | 20 | $138,239.39 | ≈ Typical |
In 2023, this provider wrote 20 Medicare prescriptions for Strensiq, about the same volume as the typical Colorado prescriber of this medication (21). Medicare paid an average of $138,239.39 per fill, versus $84,976.60 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CO prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 560 Days of Medication total across all patients in 2023 | |||
| FabrazymeAgalsidase Beta | 18 | $21,689.51 | – No State Data |
About Fabrazyme: This medication is used to treat a certain inherited disorder (Fabry disease) that causes buildup of a certain fat substance (GL-3) in some parts of your body. Show more ▾ Worsening of this disorder can lead to kidney disease, heart attack, or stroke. Agalsidase beta works by replacing an enzyme that your body lacks, which helps break down the fat substance (GL-3) in your body. This can help prevent symptoms such as pain (especially in the hands and feet), dark red spots on the skin, a decreased ability to sweat, cloudiness of the front part of the eye, stomach/intestinal problems, ringing in the ears (tinnitus), and hearing loss. In 2023, this provider wrote 18 Medicare prescriptions for Fabrazyme. Medicare paid an average of $21,689.51 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $21,689.51 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18 30-Day Fills standardized to 30-day supplies 514 Days of Medication total across all patients in 2023 | |||
| GalafoldMigalastat Hcl | 13 | $30,036.86 | ≈ Typical |
About Galafold: This medication is used for long-term treatment in people with a certain inherited disease (Fabry disease). Show more ▾ In Fabry disease, a certain enzyme in your body (alpha-galactosidase) does not work the way it should. This leads to a buildup of a certain fatty substance in your kidneys, heart, and other organs. Migalastat works by helping alpha-galactosidase work better so it can remove the fatty substance. Treatment can decrease some symptoms caused by Fabry disease, such as abdominal cramps, diarrhea, burning pain in the hands and feet, heat intolerance, skin rash, kidney/heart disease, or stroke. In 2023, this provider wrote 13 Medicare prescriptions for Galafold, about the same volume as the typical Colorado prescriber of this medication (12). Medicare paid an average of $30,036.86 per fill, versus $28,665.37 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CO prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 364 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for MATTHEW TAYLOR MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Clinical Genetics (M.D.) prescribing approach at this Aurora, CO practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among CO prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
